Drug policy: Ministry of Health is appointing a new team

The team consists of:

1) Team Chairman - Undersecretary of State in the Ministry of Health responsible for drug policy;

2) Deputy Chairman of the Team - director of the Department of Drug Policy and Pharmacy at the Ministry of Health;

3) members:

a) Main Pharmaceutical Inspector or his deputy,

b) President of the National Health Fund or his deputy,

c) Chief Sanitary Inspector or his deputy,

d) the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products or his deputy,

e) Director of the e-Health Center or his deputy,

f) President of the Agency for Health Technology Assessment and Tariffs or his deputy,

g) Director of the Department of Innovation in the Ministry of Health or his deputy,

h) Director of the Department of Analyzes and Strategies in the Ministry of Health or his deputy,

i) Director of the Department of Treatment in the Ministry of Health or his deputy,

j) representative:

- Main Pharmaceutical Inspectorate

- National Health Fund,

- Chief Sanitary Inspectorate,

- Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,

- e-Health Center,

- Agency for Health Technology Assessment and Tariffs,

- Department of Drug Policy and Pharmacy in the Ministry of Health,

- Department of Innovation in the Ministry of Health,

- Department of Analyzes and Strategies in the Ministry of Health,

- Department of Treatment in the Ministry of Health.

The task of the Team is to prepare a report resulting from the assessment of the current state of IT systems and indication of possible solutions aimed at enhancing the interoperability of systems used in drug policy and proposing the necessary legislative changes.

Regulation: HERE

Source: MZ